Wright Medical Group, Inc.
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 16, 2007
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
         
Delaware   000-32883   13-4088127
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)
         

5677 Airline Road, Arlington, Tennessee
  38002
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (901) 867-9971
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 1.01. Entry into a Material Definitive Agreement
Item 9.01. Exhibits
SIGNATURE
EXHIBIT INDEX
Ex-10.1 First Amendment to Credit Agreement


Table of Contents

Item 1.01. Entry into a Material Definitive Agreement.
On November 16, 2007, we and our domestic subsidiaries entered into the First Amendment to Credit Agreement (the Amendment) related to the Credit Agreement dated as of June 30, 2006 (the Credit Agreement), among us, our domestic subsidiaries, and a group of banks led by Bank of America, N.A.
We entered into the Amendment in anticipation of our offering of convertible senior notes due 2014 (the Notes). The Amendment authorizes us to issue and make interest payments on the Notes. Additionally, the Amendment changes the leverage ratio covenant contained in the Credit Agreement to a net leverage ratio covenant, which allows us to subtract the unrestricted cash held by us and our domestic subsidiaries in excess of $10 million from the indebtedness of us and all of our subsidiaries when calculating the ratio.
A copy of the Amendment is attached to this report as Exhibit 10.1 and is incorporated herein by reference.
Item 9.01. Exhibits.
(c) Exhibits.
     
Exhibit    
Number   Description
10.1
  First Amendment to Credit Agreement dated as of November 16, 2007, related to the Credit Agreement dated as of June 30, 2006, among Wright Medical Group, Inc., its domestic subsidiaries, and a group of banks led by Bank of America, N.A.

1


Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     Date: November 21, 2007
         
  WRIGHT MEDICAL GROUP, INC.
 
 
  By:   /s/ Gary D. Henley    
    Gary D. Henley   
    President and Chief Executive Officer   
 

2


Table of Contents

EXHIBIT INDEX
     
Exhibit    
Number   Description
10.1
  First Amendment to Credit Agreement dated as of November 16, 2007, related to the Credit Agreement dated as of June 30, 2006, among Wright Medical Group, Inc., its domestic subsidiaries, and a group of banks led by Bank of America, N.A.